Researchers at the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), have developed an artificial intelligence tool that predicts whether a patient will respond to cancer treatment drugs using individual…
Continue Reading
Funding worth A$6.5 million ($4 million) has been awarded to four genomics-focused research projects led by researchers from the University of Melbourne.These include a project that will establish a patient dataset of inherited retinal…
Continue Reading
What You Should Know:
– BillionToOne (BTO), a company dedicated to accessible and accurate genetic testing, has launched BabyPeek, a first-of-its-kind prenatal test uses advanced technology to predict a baby’s non-medical traits as early as…
Continue Reading
Professor Jane Eddleston has highlighted the positive results so far of Manchester University NHS Foundation Trust’s Hive electronic patient record (EPR) in a keynote session at Rewired 2024.The joint group medical director at the…
Continue Reading
The Royal Orthopaedic Hospital NHS Foundation Trust has embarked on a number of impactful digital initiatives in recent years, with more bold plans underway. Head of digital transformation at the trust, Gavin Newman, speaks…
Continue Reading
Singapore is one of the major adopters of AI in healthcare in the world, particularly in areas such as disease detection and improving patient outcomes. What drives this significant feat is an effective collaboration among…
Continue Reading
What You Should Know:
Sika Health, a leading HSA/FSA payment solution for eCommerce merchants, today announced the launch of Sika Health Marketplace, the go-to shopping destination that makes it easy and hassle-free for consumers to…
Continue Reading
Researchers at the University of Massachusetts Amherst have developed a new method of detecting very small amounts of DNA. The breakthrough could allow clinicians to spot genetic markers of disease at the point-of-care, as…
Continue Reading
A groundbreaking study reveals the effectiveness of liquid biopsy tests in guiding personalized treatment for non-small cell lung cancer (NSCLC) patients. Unlike conventional methods, these tests focus on circulating tumor DNA (ctDNA) levels, providing…
Continue Reading
Blood cancers are classified into three main types, each with several subtypes. The underlying cause is attributed to mutations in the DNA of blood cells that disrupt the normal control mechanisms that regulate cell…
Continue Reading
